세계 연구용 항체 시장 규모는 2023년 37억 달러에서 예측 기간 동안 9.2%의 연평균 복합 성장률(CAGR)을 나타내고, 2028년에는 58억 달러 규모로 성장할 것으로 예상됩니다.
ELISA 부문은 2023년 7억 7,010만 달러에서 10.0%의 연평균 복합 성장률(CAGR)을 나타내고, 2028년에는 12억 달러 규모에 이를 것으로 예상됩니다. 또한, 웨스턴 블로팅 부문은 2023년 8억 5,640만 달러에서 6.8%의 연평균 복합 성장률(CAGR)을 나타내고, 2028년에는 12억 달러에 육박할 것으로 예상됩니다.
세계의 연구용 항체 시장을 조사했으며, 시장 및 기술 배경, 시장 영향요인 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, ESG 전개, 기술 동향, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 요약 및 하이라이트
제3장 시장 및 기술 배경
- 경위와 현황
- 항체와 제작 배경
- 현황과 과제
- 항체 기술 개요
- 기존 항체 생성 기술
- 항체 생성 기술
- 항체 검증 방법
- 연구용 항체 시장 동향
- 구매 요인 분석
- 제삼자 품질 평가 시스템
- 연구 보조금
- 저널 인용 분석
- 항체 제작과 응용 기술 동향
제4장 연구용 항체
- 효소 면역 흡착법/효소 면역 흡착 스포트
- 직접 ELISA
- 간접 ELISA
- 경쟁 ELISA
- 샌드위치 ELISA
- ELISPOT 어세이
- FluoroSpot 어세이
- ELISA 새로운 기술 또는 플랫폼
- 웨스턴 블로팅
- 1차원 겔 전기영동
- 2차원 겔 전기영동
- 새로운 웨스턴 블로팅 기술과 플랫폼
- 면역조직화학
- 다중 염색
- 저굴곡 염색
- 유세포분석기
- 새로운 유세포분석기 기술/플랫폼
- 면역 세포 화학과 면역 형광 염색
- 크로마틴 면역 침강
- 기타 항체 용도
- 항체 어레이
제5장 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
제6장 시장 내역 : 항체 유형별
- 세계 시장 : 항체 유형별
- 1차 항체
- 2차 항체
제7장 시장 내역 : 클론성별
- 세계 시장 : 클론 성별
- 다중클론항체
- 단일클론항체
- 재조합 항체
제8장 시장 내역 : 주요 반응성별
- 세계 시장 : 주요 반응성 별
- 인간(Anti-Human)
- 마우스(Anti-Mouse)
- 쥐(Anti-Rat)
- 기타
제9장 시장 내역 : 용도별
- 세계 시장 : 용도별
- 웨스턴 블로팅
- 유세포분석기
- 면역조직화학
- 면역 세포 화학
- 면역 형광 염색
- 면역 침강
- ELISA
제10장 시장 내역 : 숙주 유형별
- 세계 시장 : 숙주 유형별
- 토끼 숙주 종
- 염소 숙주 종
- 마우스 숙주 종
- 양 숙주 종
- 당나귀 숙주 종
- 기타 숙주 종
제11장 시장 내역 : 최종사용자별
- 세계 시장 : 최종사용자별
- 대학 및 학술기관
- 제약 및 바이오 기술 기업
- 기타
제12장 시장 내역 : 지역별
- 세계 시장 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제13장 연구용 항체 산업 지속가능성 : 환경·사회·거버넌스 측면엔서의 지속가능성
- 연구용 항체 업계에서 ESG의 중요성
- ESG 평가와 지표 : 데이터 이해
- 연구용 항체 제조업계에서의 ESG 실천
- 환경 측면의 성과
- 사회 측면의 성과
- 거버 측면의 성과
- 사례 연구
- BCC의 견해
제14장 항체 발견과 생성을 위한 최신 기술
- 기존 항체 발견 및 생성 기술
- 동물 혈장 분리
- 잡종 세포 생성
- B세포 스크리닝
- 디스플레이 기술
- 새로운 항체 발견 및 생성 기술
- 항체 제조 기술 새로운 동향
- 폴리클로널 항체 배열 결정
- 단일 B세포 시퀀싱
- 머신러닝을 이용한 발견과 생성
- 항체 발견 기술의 장단점
- 항체 제작과 기술 사례
- REpAb 기술
- Boehringer Ingelheim 제휴
- EABR 기술에 의한 COVID-19 백신
- 최초 치료용 항체
- 과제와 향후 연구 방향성
제15장 승인을 획득한 단일클론항체 : 2018-2023년
제16장 M&A 미 ㅊ벤처 자금조달 전망
- 인수합병(M&A) 분석
- 인수합병(M&A) 거래 : 2018-2023년
제17장 경쟁 구도
- 세계 기업 순위
- WHO의 Anti-SARS-CoV-2면역글로불린 국제기준
- 주요 기업의 항체 TOP 100
제18장 기업 개요
- ABCAM PLC
- ABSOLUTE ANTIBODY LTD.
- AGILENT TECHNOLOGIES INC.
- BD BIOSCIENCES
- BIO-RAD(ABD SEROTEC)
- BIO-TECHNE
- CELL SIGNALING TECHNOLOGY INC.
- DANAHER
- JACKSON IMMUNORESEARCH LABORATORIES INC.
- LONZA
- MERCK KGAA(SIGMA-MILLIPORE)
- ROCKLAND IMMUNOCHEMICALS INC.
- SANTA CRUZ BIOTECHNOLOGY INC.
- SINO BIOLOGICAL INC.
- THERMO FISHER SCIENTIFIC INC.
- UNITED STATES BIOLOGICAL
제19장 부록 : 두자어
LSH
Highlights:
The global market for research antibodies is estimated to increase from $3.7 billion in 2023 to reach $5.8 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.
The global market for research antibodies for ELISA is estimated to increase from $770.1 million in 2023 to reach more than $1.2 billion by 2028, at a CAGR of 10.0% from 2023 through 2028.
The global market for research antibodies for western blot is estimated to increase from $856.4 million in 2023 to reach nearly $1.2 billion by 2028, at a CAGR of 6.8% from 2023 through 2028.
Report Scope:
This study focuses on the market side of research antibodies, as opposed to the technical side. Different market segments for this specific market are covered. Application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC)(types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including recombinant antibodies; customer type-based market segments include universities and academic institutions, pharmaceutical and biotech companies and other types of customers (e.g., governmental research labs, contract research organizations [CROs]); geography-based market segments include North America, Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.
In this report, the market for research antibodies is segmented based on product type, clonality, host species, major reactivities, applications, end-user, and geography. Based on application type, the market is segmented into enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC) (i.e., types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC). Based on major reactivities, the market is segmented into anti-human, anti-rat and anti-mouse. The market is also presented based on product type, which is further segmented into primary and secondary antibodies.
The market has been geographically segmented into the North America, Europe, Asia-Pacific and Rest of the World (i.e., South America, Middle East and Africa) regions. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, and GCC countries) will be covered in the regional segment. For market estimates, data will be provided for 2022 as the base year, with estimates for 2023 and forecast value for 2028.
Report Includes:
- 145 data tables and 45 additional tables
- An overview of the global market landscape related to the research antibodies
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by product, clonality, application, major reactivities, host species, end-user, and geographical region
- Discussion on the factors affecting the companies' market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
- Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
- Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry's growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
- Coverage of new discoveries in biological sciences, rapid technological developments in the IVD industry, new antibody technologies and antibody types, and assessment of antibody-based drug discovery and development
- Discussion on advantages and disadvantages of antibody discovery technologies with examples of antibody production, and information on REpAb technology
- Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
- Examination of environmental, social, and corporate governance (ESG) developments, a relevant patent analysis; and merger and acquisitions (M&A), venture fundings, and emerging technologies in the global research antibodies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses, including Abcam Plc, Thermo Fisher Scientific Inc., Cell Signaling Technology Inc., Merck KGaA, Sino Biological Inc., and Bio-Rad
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- What's New in this Update
- Methodology
- Information Sources
- Geographic Breakdown
- Segmentation Breakdown
Chapter 2 Summary and Highlights
- Market Overview
- Market Summary
Chapter 3 Market and Technology Background
- Introduction
- History and Current State
- Background of the Antibody and Its Production
- Current Status and Issues
- Overview of Antibody Technology
- Traditional Antibody Generation Technologies
- Antibody Generation Technologies
- Antibody Validation Methods
- Trends in the Market for Research Antibodies
- Purchasing Factors Analysis
- Third-Party Quality Evaluation Systems
- Research Grants
- Journal Citations Analysis
- Technological Trends in Antibody Production and Application
Chapter 4 Research Antibodies
- Introduction
- Enzyme-Linked Immunosorbent Assay/Enzyme-Linked Immunosorbent Spot
- Direct ELISA
- Indirect ELISA
- Competitive ELISA
- Sandwich ELISA
- ELISPOT Assays
- FluoroSpot Assays
- Emerging Technologies or Platforms in ELISA
- Western Blot
- One-Dimensional Gel Electrophoresis
- Two-Dimensional Gel Electrophoresis
- Emerging Technologies and Platforms in Western Blot
- Immunohistochemistry
- Multiplexed Staining
- Low-Flexed Staining
- Flow Cytometry
- Emerging Technologies/Platforms in Flow Cytometry
- Immunocytochemistry and Immunofluorescent Staining
- Chromatin Immunoprecipitation
- Other Antibody Applications
- Antibody Arrays
Chapter 5 Market Dynamics
- Market Drivers
- New Discoveries in Biological Sciences
- Rapid Technological Developments in the In Vitro Diagnostic Industry
- New Antibody Technologies and Types
- Antibody-Based Drug Discovery and Development
- Developed and Increasing Research Areas
- Increased Government Funding in Emerging Markets
- Need for Further Human Genomic and Proteomic Research
- Need for Quality Antibodies in the Current Research Community
- Need for Antibody Custom Services
- New Application-Focused Technology Platforms
- Market Restraints
- Limited Research Funding
- Low Validation Technologies
- Decline in Suppliers
- Decrease in Market Acceptance or Brand Trust
- Market and Economic Risk
- Market Opportunities
- Market Expansion into Emerging Countries
- Development of Novel Research Antibodies
Chapter 6 Market Breakdown by Type of Antibody
- Global Market for Research Antibodies by Type
- Primary Antibodies
- Secondary Antibodies
Chapter 7 Market Breakdown by Clonality
- Global Market for Research Antibodies by Clonality
- Polyclonal Antibodies
- Monoclonal Antibodies
- Recombinant Antibodies
Chapter 8 Market Breakdown by Major Reactivity
- Global Market for Research Antibodies by Major Reactivity
- Human (Anti-Human)
- Mouse (Anti-Mouse)
- Rat (Anti-Rat)
- Others
Chapter 9 Market Breakdown by Application
- Global Market for Research Antibodies by Application
- Western Blot
- Flow Cytometry
- Immunohistochemistry
- Immunocytochemistry
- Immunofluorescent Staining
- Immunoprecipitation
- ELISA
Chapter 10 Market Breakdown by Host Species
- Global Market for Research Antibodies by Host Species
- Rabbit Host Species
- Goat Host Species
- Mouse-Host Species
- Sheep Host Species
- Donkey Host Species
- Other Host Species
Chapter 11 Market Breakdown by End User
- Global Market for Research Antibodies by End User
- Universities and Academic Institutions
- Pharma and Biotech Companies
- Other End Users
Chapter 12 Market Breakdown by Region
- Global Market for Research Antibodies by Region
- North America
- Europe
- Asia-Pacific
- Rest of World
Chapter 13 Sustainability in the Research Antibodies Industry: An Environment, Social and Governance Sustainability in the Research
- Importance of Environment, Social and Governance in the Research Antibodies Manufacturing Industry
- Environment, Social and Governance Ratings and Metrics: Understanding the Data
- Environmental, Social and Governance Practices in the Research Antibodies Manufacturing Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Case Studies
- BCC Research Viewpoint
Chapter 14 Emerging Technology for Antibody Discovery and Generation
- Traditional Antibody Discovery and Generation Technologies
- Animal Plasma Isolation
- Hybridoma Generation
- B Cell Screening
- Display Technologies
- Emerging Antibody Discovery and Generation Technologies
- Emerging Trends in the Antibody Production Technologies
- Polyclonal Antibody Sequencing
- Single B Cell Sequencing
- Machine Learning-Assisted Discovery and Generation
- Advantages and Disadvantages of Antibody Discovery Technol0gies
- Examples of Antibody Production and Technologies
- REpAb Technology
- Boehringer Ingelheim's Partnership with Company
- COVID-19 Vaccines by EABR Technology
- First Therapeutic Antibody
- Challenges and Future Research Direction
Chapter 15 Approved Monoclonal Antibodies, 2018-2023
Chapter 16 M&A and Venture Funding Outlook
- Mergers and Acquisitions Analysis
- Merger and Acquisition Deals: 2018-2023
Chapter 17 Competitive Landscape
- Global Company Market Ranking
- Distribution of the WHO's International Standard for Anti-SARS-CoV-2 Immunoglobulin
- Top 100 Antibodies by Major Key Companies
Chapter 18 Company Profiles
- ABCAM PLC
- ABSOLUTE ANTIBODY LTD.
- AGILENT TECHNOLOGIES INC.
- BD BIOSCIENCES
- BIO-RAD (ABD SEROTEC)
- BIO-TECHNE
- CELL SIGNALING TECHNOLOGY INC.
- DANAHER
- JACKSON IMMUNORESEARCH LABORATORIES INC.
- LONZA
- MERCK KGAA (SIGMA-MILLIPORE)
- ROCKLAND IMMUNOCHEMICALS INC.
- SANTA CRUZ BIOTECHNOLOGY INC.
- SINO BIOLOGICAL INC.
- THERMO FISHER SCIENTIFIC INC.
- UNITED STATES BIOLOGICAL
Chapter 19 Appendix: Acronyms
